New Evidence of Exocrine Pancreatopathy in Pre-symptomatic and Symptomatic Type 1 Diabetes
- 31 August 2019
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 19 (10) , 92
Abstract
Type 1 diabetes (T1D) is one of the most frequent chronic autoimmune diseases in humans, characterized by the lack of insulin production resulting in high blood glucose levels and lifelong requirement of exogenous insulin administration for survival. It is now recognized that the autoimmune process begins years before the clinical onset, in a stage called pre-symptomatic T1D, in which the presence of β-cell-specific autoantibodies is detectable. Our aim is to review evidence for T1D as a “whole-pancreas disease,” featured by both endocrine and exocrine pancreas alterations already at early disease stages.Keywords
This publication has 66 references indexed in Scilit:
- Insulitis in human type 1 diabetesIslets, 2011
- Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patientsJournal of Clinical Investigation, 2011
- MRI appearance of the pancreas in patients with cystic fibrosis: a comparison of pancreas volume in diabetic and non-diabetic patientsBritish Journal of Radiology, 2010
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesNature Genetics, 2009
- Rare Variants of IFIH1 , a Gene Implicated in Antiviral Responses, Protect Against Type 1 DiabetesScience, 2009
- Amylase α-2A AutoantibodiesDiabetes, 2009
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunctionNature Genetics, 2005
- Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitusActa Diabetologica, 2000
- Diagnostic Tests and Procedures in Acute PancreatitisNew England Journal of Medicine, 1984